Elekta to deliver advanced cancer management solutions to Providence Health & Services

Order by Providence includes wide range of Elekta hardware, software and
services
STOCKHOLM, April 14 – Elekta announced today that Providence Health & Services
(Renton, Washington, USA) – the nation’s third largest not-for-profit health
system – has ordered multiple Elekta cancer management solutions, including
radiation therapy systems and upgrades, oncology information systems and
multiyear service contracts for its hospitals, clinics and other health care
facilities in Washington, Alaska, California, Montana and Oregon.

In 2012, Providence and Seattle’s Swedish Health Services affiliated, bringing
together two of the region’s largest health care organizations. The Swedish
Cancer Institute was a long-time partner with Elekta in the provision of cancer
management resources in the northwest.

“Our new partnership with Providence continues a mutually beneficial tradition
in which two organizations work together to build value for thousands of
individuals in this region who need world-class health care,” says Jay Hoey,
Executive Vice President, Elekta North America. “We’re jointly creating
something that is more than a traditional vendor-customer relationship – it’s an
alliance of two entities with a common vision to improve patients’ lives.”

In the agreement, Providence Health & Services will acquire several Versa
HD™ (http://www.versahd.com/) systems, Elekta’s most advanced radiation therapy
system (linear accelerator), featuring sophisticated beam shaping technology
combined with high dose rate delivery. Versa HD is designed to give clinicians
the flexibility to deliver conventional therapies to treat a wide range of small
and large tumors throughout the body, while also enabling treatment of highly
complex cancers that require extreme targeting precision.

In addition, Elekta will provide upgrades to several existing Elekta systems,
including the integration of Agility™ (http://www.elekta.com/agility) 160-leaf
multileaf collimator (MLC) and XVI (5.0) (http://www.elekta.com/XVI) software.

In a significant acquisition of Elekta software, Providence also will begin a
system-wide conversion of its existing oncology information system to
MOSAIQ® (http://www.elekta.com/MOSAIQ) Oncology Information System.

Installation of the Elekta systems is set to begin immediately, continuing
through the end of 2016.

# # #

For further information, please contact:
Gert van Santen, Group Vice President Corporate Communications, Elekta AB
Tel: +31 653 561 242, e-mail: gert.vansanten@elekta.com
Time zone: CET: Central European Time

Tobias Bülow, Director Financial Communication, Elekta AB
Tel: +46 722 215 017, e-mail: tobias.bulow@elekta.com
Time zone: CET: Central European Time
The above information is such that Elekta AB (publ) shall make public in
accordance with the Securities Market Act and/or the Financial Instruments
Trading Act. The information was published at 07:30 CET on April 14, 2015.

About Elekta
Elekta is a human care company pioneering significant innovations and clinical
solutions for treating cancer and brain disorders. The company develops
sophisticated, state-of-the-art tools and treatment planning systems for
radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing
software systems across the spectrum of cancer care. Stretching the boundaries
of science and technology, providing intelligent and resource-efficient
solutions that offer confidence to both health care providers and patients,
Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000
hospitals worldwide. Elekta employs around 3,800 employees globally. The
corporate headquarters is located in Stockholm, Sweden, and the company is
listed on NASDAQ Stockholm. Website: www.elekta.com.